Cargando…
Physiological Considerations for Modeling in vivo Antibody-Target Interactions
The number of therapeutic antibodies in development pipelines is increasing rapidly. Despite superior success rates relative to small molecules, therapeutic antibodies still face many unique development challenges. There is often a translational gap from their high target affinity and specificity to...
Autores principales: | Dunlap, Tyler, Cao, Yanguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912916/ https://www.ncbi.nlm.nih.gov/pubmed/35281913 http://dx.doi.org/10.3389/fphar.2022.856961 |
Ejemplares similares
-
Physiological and Pharmaceutical Considerations for Rectal Drug Formulations
por: Hua, Susan
Publicado: (2019) -
Therapeutic Use of Vitamin C in Cancer: Physiological Considerations
por: Roa, Francisco J., et al.
Publicado: (2020) -
Characterizing Pharmacokinetics in Children With Obesity—Physiological, Drug, Patient, and Methodological Considerations
por: Gerhart, Jacqueline G., et al.
Publicado: (2022) -
Modeling the dynamics of antibody–target binding in living tumors
por: Tang, Yu, et al.
Publicado: (2020) -
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
por: Basu, Sumit, et al.
Publicado: (2020)